Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study

Cancer

Volumn 122, Issue 3, 2016, Pages 438-446

  Tevaarwerk, Amye J ^a   Lee, Ju Whei ^b   Terhaar, Abigail ^a   Sesto, Mary E ^a   Smith, Mary Lou ^c   Cleeland, Charles S ^d   Fisch, Michael J ^d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Research Advocacy Network   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

advanced cancer; employment; metastatic cancer; symptom burden; treatment toxicity

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURVIVOR; CAUCASIAN; COLORECTAL CANCER; EMPLOYMENT; FEMALE; HUMAN; JOB CHANGE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PARTTIME EMPLOYMENT; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SOFT TISSUE METASTASIS; UNITED STATES; VISCERAL METASTASIS; WORK DISABILITY; BREAST TUMOR; CLINICAL TRIAL; COLORECTAL TUMOR; COMPLICATION; DISEASE COURSE; EPIDEMIOLOGY; ETHNOLOGY; LUNG TUMOR; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS; PATHOLOGY; PERU; PREVALENCE; PROSPECTIVE STUDY; PROSTATE TUMOR; SELF REPORT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SURVIVOR; TIME FACTOR; TREATMENT OUTCOME; WORK;

ADULT; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EMPLOYMENT; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PERU; PREVALENCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SELF REPORT; SEVERITY OF ILLNESS INDEX; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; WORK;

EID: 84952360073     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29656     Document Type: Article

References (40)

1. Surveillance, Epidemiology, and End Results Program. SEER stat fact sheets: all cancer sites. http://seer.cancer.gov/statfacts/html/all.html. Accessed May 13, 2015.
2. Siegel R, Ma J, Zou Z, Jemal A,. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29.
3. Thorne SE, Oliffe JL, Oglov V, Gelmon K,. Communication challenges for chronic metastatic cancer in an era of novel therapeutics. Qual Health Res. 2013; 23: 863-875.
4. Rose T, Caracciolo J, Gatenby R,. Cancer survivorship, a unique and growing cohort in medical practice: radiology perspective. Am J Med. 2013; 126: 759-767.
5. Siegel R, Naishadham D, Jemal A, et al., Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29.
6. Spelten ER, Sprangers MA, Verbeek JH,. Factors reported to influence the return to work of cancer survivors: a literature review. Psychooncology. 2002; 11: 124-131.
7. Taskila T, Martikainen R, Hietanen P, Lindbohm ML,. Comparative study of work ability between cancer survivors and their referents. Eur J Cancer. 2007; 43: 914-920.
8. Mols F, Thong MS, Vreugdenhil G, Van De Poll-Franse LV,. Long-term cancer survivors experience work changes after diagnosis: results of a population-based study. Psychooncology. 2009; 18: 1252-1260.
9. Steiner JF, Cavender TA, Nowels CT, et al., The impact of physical and psychosocial factors on work characteristics after cancer. Psychooncology. 2008; 147: 138-147.
10. Hansen JA, Feuerstein M, Calvio LC, Olsen CH,. Breast cancer survivors at work. J Occup Environ Med. 2008; 50: 777-784.
11. Taskila T, Lindbohm ML,. Factors affecting cancer survivors' employment and work ability. Acta Oncol. 2007; 46: 446-451.
12. Gudbergsson SB, Fossa SD, Borgeraas E, Dahl AA,. A comparative study of living conditions in cancer patients who have returned to work after curative treatment. Support Care Cancer. 2006; 14: 1020-1029.
13. Centers for Disease Control and Prevention (CDC). Cancer survivorship-United States, 1971-2001. MMWR Morb Mortal Wkly Rep. 2004; 53: 526-529.
14. Glare PA,. Early implementation of palliative care can improve patient outcomes. J Natl Compr Canc Netw. 2013; 11 (suppl 1): S3-S9.
15. Mayer M, Grober S,. Silent voices: women with advanced (metastatic) breast cancer share their needs and preferences for information, support and practical services. http://www.lbbc.org/About-LBBC/LBBC-Research/2006-Silent-Voices-Metastatic-Breast-Cancer-Survey. Accessed May 13, 2015.
16. Bouknight RR, Bradley CJ, Luo Z,. Correlates of return to work for breast cancer survivors. J Clin Oncol. 2006; 24: 345-353.
17. Bradley CJ, Neumark D, Bednarek HL, Schenk M,. Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ. 2005; 24: 137-160.
18. Bradley CJ, Oberst K, Schenk M,. Absenteeism from work: the experience of employed breast and prostate cancer patients in the months. Psychooncology. 2006; 747: 739-747.
19. Bradley CJ, Bednarek HL, Neumark D,. Breast cancer survival, work, and earnings. J Health Econ. 2002; 21: 757-779.
20. Drolet M, Maunsell E, Mondor M, et al., Work absence after breast cancer diagnosis: a population-based study. CMAJ. 2005; 173: 765-771.
21. Short PF, Vasey JJ, Tunceli K,. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005; 103: 1292-1301.
22. Kennedy F, Haslam C, Munir F, Pryce J,. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care (Engl). 2007; 16: 17-25.
23. Main DS, Nowels CT, Cavender TA, Etschmaier M, Steiner JF,. A qualitative study of work and work return in cancer survivors. Psychooncology. 2005; 14: 992-1004.
24. Fisch M, Lee JW, Manola J, et al., Survey of disease and treatment-related symptoms in outpatients with invasive cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study) [abstract]. J Clin Oncol. 2009; 27 (suppl): 9619.
25. Cleeland CS, Mendoza TR, Wang XS, et al., Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000; 89: 1634-1646.
26. Jagsi R, Hawley ST, Abrahamse P, et al., Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer. 2014; 120: 1854-1862.
27. Cleeland CS, Mayer M, Dreyer NA, et al., Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: results from a substudy of the VIRGO observational cohort study. Breast. 2014; 23: 763-769.
28. Sesto M, Wachowiak R, Tevaarwerk A, Faatin M, Heidrich S, Wiegmann D,. Improving employment outcomes of breast cancer survivors: development of a Web-based educational and decision support tool. Proc Hum Factors Ergon Soc Annu Meet. 2011; 55: 1333-1337.
29. Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS,. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer. 2011; 117: 2779-2790.
30. Mosher CE, DuHamel KN,. An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psychooncology. 2012; 21: 100-107.
31. Paice JA, Von Roenn JH,. Under- or overtreatment of pain in the patient with cancer: how to achieve proper balance. J Clin Oncol. 2014; 32: 1721-1726.
32. Greco MT, Roberto A, Corli O, et al., Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014; 32: 4149-4154.
33. Wilwerding MB, Loprinzi CL, Mailliard JA, et al., A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer. 1995; 3: 135-138.
34. Ishida T, Suga A, Akagi M, Kamei C,. Effects of anti-dementia drugs on morphine-induced somnolence. Biol Pharm Bull. 2009; 32: 1862-1865.
35. Nissen MJ, Tsai ML, Blaes AH, Swenson KK,. Breast and colorectal cancer survivors' knowledge about their diagnosis and treatment. J Cancer Surviv. 2011; 6: 20-32.
36. Rocque GB, Wisinski KB, Buhr KA, et al., Development and evaluation of a survey to assess survivor knowledge change after survivorship care plans: WiSDOM-B (Wisconsin Survey of Cancer Diagnosis and Management in Breast Cancer). J Cancer Educ. 2014; 29: 270-277.
37. Tripathy D, Rugo HS, Kaufman PA, et al., The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. BMC Cancer. 2014; 14: 1-11.
38. White CB, Smith ML, Abidoye D, Lalla D,. Impacts of toxicity on patient treatment choices for metastatic breast cancer [abstract]. J Clin Oncol. 2012; 30 (suppl 34): 18.
39. White CB, Smith ML, Abidoye O, Lalla D,. Examining patient treatment choices involving efficacy, toxicity, and cost tradeoffs in the metastatic breast cancer setting [abstract]. Cancer Res. 2012; 72 (24 suppl): P6-09-11.
40. Hurvitz S, Jahanzeb M, Kaufman P, et al., Patient-reported outcomes (PROs) from the Systemic Therapies for HER2-Positive Metastatic Breast Cancer (MBC) Registry Study (SystHERs): eliciting the patient experience [abstract]. J Clin Oncol. 2014; 32 (suppl 30): 286.